Volume | 373,405 |
|
|||||
News | - | ||||||
Day High | 1.7899 | Low High |
|||||
Day Low | 1.6202 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Longeveron Inc | LGVN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.67 | 1.6202 | 1.7899 | 1.75 | 1.67 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,365 | 373,405 | $ 1.72 | $ 640,884 | - | 1.60 - 44.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:06:54 | 1 | $ 1.74 | USD |
Longeveron Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 25.13M | - | 709k | -22.21M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Longeveron News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LGVN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.92 | 2.10 | 1.60 | 1.82 | 368,965 | -0.21 | -10.94% |
1 Month | 3.16 | 5.47 | 1.60 | 2.59 | 6,741,742 | -1.45 | -45.89% |
3 Months | 5.345 | 5.858 | 1.60 | 2.69 | 2,323,639 | -3.64 | -68.01% |
6 Months | 19.20 | 23.90 | 1.60 | 3.90 | 1,243,329 | -17.49 | -91.09% |
1 Year | 28.10 | 44.00 | 1.60 | 7.92 | 749,166 | -26.39 | -93.91% |
3 Years | 60.42 | 450.00 | 1.60 | 140.37 | 1,819,169 | -58.71 | -97.17% |
5 Years | 100.00 | 450.00 | 1.60 | 138.00 | 1,774,224 | -98.29 | -98.29% |
Longeveron Description
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS). |